Clinuvel Pharmaceuticals (CLVLY)

[sante1]

Closingprice AUS $8,21

Quarterly report 31th of January. Interim report the 17th of february

CUV is in the PUMPING-UP mode right now and a second one will come soon in the period after the release of 31th January.

Don't think Clinuvel is an exception! It's the Marketmakers (read Vulgars) - Game right now.

Before the end of this month, that's to say what PW promised the Market and mark my words PWs PR is unpredictable as usual.
That means that it never happens in between but moreover at the end otherwise it was already released. Tomorrow Thuesday 31 January 2017 or even somewhat later.
Make your beths.

Tomorrows release alone doesn't give the whole picture. It will still raises questions which no one here can clearly answer, which is bad for the SP.
We have to wait for the interim-results PW will present next month.
Those 2 together will provide us a better vue where Clinuvel stands right now, how well the distribution is going on within the EU, what it will bring for the rest of the year.

The facts have to be combined together first. Reading them seperately makes no sence. That's to say what I'm thinking.

For a Marketmaker this is the best time. He makes use of the uncertainty in the Market. We on this board are a great help for this "Man" (Vulgar)!

Clinuvel = Quality, are you convinced of that? Think forward, don't look back and certainly not let yourself in with the Issues of the day.

Do you know how many upcoming biotech companies reach Their End Goal? Keep the answer in your mind.

Clinuvel will be the Talk of the Town in no time. The US investors will play a very important role in that. Scenesse need to be granted in the US first! Europe and Australia are a different kind of investors then the ones in the US.
The European one is a very conservative one, that's for sure.


Clinuvel is on the right track, that's for sure. Good work needs time.



According investmart the interim report will be released 17 days later.


https://www.investsmart.com.au/shares/asx-c...uticals-limited

Calendar of Events
Date Event
26 October 2017 Report (Annual)
24 August 2017 Report (Prelim)
17 February 2017 Report (Interim)




Substantial Shareholders

Holding Name
4,720,236 (9.89%) Lagoda Investment Management, L.P
4,531,171 (9.49%) FIL Limited
3,721,898 (7.80%) Dr Philippe Jacques Wolgen

Who is FIL Limited?

http://www.bloomberg.com/research/stocks/p...vcapId=12723484